Feeds:
Posts
Comments

Posts Tagged ‘FDA’

NEW PROSTATE CANCER INFOLINK: The US Food and Drug Administration is warning companies offering genetic tests for diseases – including prostate cancer – that their claims can’t be backed up by research data.

Mike Scott says the prostate cancer ones are, as yet, not particularly useful, and he sets out criteria for companies to meet as more tests are developed and marketed over the next five years. READ MORE>

Read Full Post »

PROSTABLOG NZ: At last – the FDA has approved Provenge, the new and highly promising treatment for men with advanced prostate cancer. READ MORE>

Read Full Post »

NEW PROSTATE CANCER INFOLINK: Long-awaited advanced prostate cancer drug Provenge is a step closer to being available with news the manufacturing company has completed its full application to the FDA. READ MORE>


Read Full Post »

NEW YORK TIMES: Denosumab, a new drug to prevent fractures in men undergoing prostate cancer hormone treatment, is likely to get FDA approval for high risk cases only. READ MORE>

An FDA advisory committee has voted against three of four possible uses for breast and prostate cancer patients whose therapy can weaken bones. The FDA will decide in October.

Read Full Post »

JUNE 25: REUTERS: OncoGenex Pharmaceuticals Inc says it has reached an agreement with US health regulators to amend the design of a late-stage trial of its lead prostate cancer drug, OGX-011. READ MORE>

Read Full Post »